Ronald Simon

Ontro Inc. is engaged in the research and development of integrated thermal containers. Company has a proprietary technology which it has incorporated into a proposed product line of fully contained self-heating beverage containers designed to heat liquid contents such as coffee, tea, hot chocolate, soups, and alcoholic beverages. These containers are similar to typical beverage containers in size and shape and are activated by the consumer to heat the contents within a few minutes. The company seeks to develop and expand a consumer market for remote and mobile heating of beverages and other products.

Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA.

Galiot Capital Corp. is a real estate investment trust. The company invests in residential mortgage-backed securities sponsored or guaranteed by a government agency. The company invests in pass-through securities and collateralized mortgage obligations. The company is managed and advised by Fischer Francis Trees & Watts, Inc. Galiot Capital was organized in February 2008 and is headquartered in New York, NY

Softnet Systems, Inc. provides technical consultation, customization, troubleshooting, and deployment of speech recognition systems. The company was founded by Larry Allen in 1986 and is headquartered in Phoenix, AZ.